Your browser does not support the audio element. Earlier this month, the Food and Drug Administration announced it would not approve the use of MDMA, also known as ecstasy, in the treatment of Post Traumatic Stress Disorder. The agency instead asked drugmaker Lykos Therapeutics to further study the safety and efficacy of the treatment.